Showing results (451-460 of 1,736) with videos related to

Sort By:
Pageof 174
Harm Reduction Journal|April 22, 2022
Peer-facilitated treatment access for hepatitis C: the Live Hep C Free projectJulia A Silano, Carla Treloar, Kyle Leadbeatter, et al.
Harm Reduction Journal|March 16, 2022
Setting the policy agenda for the treatment of substance use disorders in IranSaeid Mirzaei, Vahid Yazdi-Feyzabadi, Mohammad Hossein Mehrolhassani, et al.
Harm Reduction Journal|March 18, 2022
Indigenous people in Aotearoa New Zealand are overrepresented in cannabis convictionsWetini Rapana, Taylor Winter, Ririwai Fox, et al.
Harm Reduction Journal|April 18, 2022
"We need to build a better bridge": findings from a multi-site qualitative analysis of opportunities for improving opioid treatment services for youthKirsten Marchand, Oonagh Fogarty, Katrina Marie Pellatt, et al.
Harm Reduction Journal|March 22, 2022
The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case studyBrendan Lew, Claire Bodkin, Robin Lennox, et al.
Harm Reduction Journal|October 14, 2021
Recovery capital among people receiving treatment for opioid use disorder with buprenorphineAnna Beth Parlier-Ahmad, Mishka Terplan, Dace S Svikis, et al.
Harm Reduction Journal|October 15, 2021
Facilitators and barriers to the regulation of medical cannabis: a scoping review of the peer-reviewed literatureMohammad Ali Ruheel, Zoya Gomes, Sana Usman, et al.
Harm Reduction Journal|April 13, 2022
Different phases of ATS use call for different interventions: a large qualitative study in EuropeNienke Liebregts, Rafaela Rigoni, Benjamin Petruželka, et al.
Harm Reduction Journal|June 26, 2019
Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research projectHenning Pettersen, Morten Brodahl, Jeanette Rundgren, et al.
Harm Reduction Journal|March 29, 2022
How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre studyMorgane Guillou Landreat, Antoine Dany, Gaelle Challet Bouju, et al.
Pageof 174